ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Innovation Pharmaceuticals Doses First Cohort of Oral Brilacidin for Ulcerative Colitis
January 19, 2020Innovation Pharmaceuticals has dosed the first cohort in its Phase 1 trial to investigate the use of delayed release tablets for colonic delivery of Brilacidin in healthy volunteers. This study formally launches the Company’s clinical program in Ulcerativ
Pharma Sources Insight January 2025
